Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-16-002469
Filing Date
2016-07-05
Accepted
2016-07-05 16:51:13
Documents
1
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 2973
  Complete submission text file 0001123292-16-002469.txt   4241
Mailing Address
Business Address
BARLIANT RONALD (Reporting) CIK: 0001288093 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 161751185

Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations